company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3041000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3041000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1625000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1625000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1416000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26173000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43485000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69658000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-68242000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,325000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,759000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-640000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-206000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-68448000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1013000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-69461000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-69461000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-69461000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,347300000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,347300000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,340252000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:41:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3284000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3284000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1791000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1791000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1493000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37786000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45113000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,82899000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-81406000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,313000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,999000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3660000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2974000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-84380000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-369000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-84011000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-84011000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-84011000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,340457000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,340457000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,336000000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:20:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2420000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2420000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1399000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1399000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1021000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52685000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28943000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81628000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-80607000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,297000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1283000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-823000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,163000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-80444000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-565000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-79879000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-79879000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-79879000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,341302000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,341302000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,347300000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 20:23:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3992000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3992000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1171000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1171000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2821000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25174000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36195000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61369000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-58548000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,314000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,604000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,160000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,450000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-58098000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3718000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61816000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61816000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61816000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,335400000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,335400000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,333936000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39247000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39247000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5131000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5131000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34116000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55078000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30375000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,85453000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-51337000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,265000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2087000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1114000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,708000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-50629000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-565000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50064000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50064000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50064000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,369823000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,369823000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,357600000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:08:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,72038000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,72038000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6620000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6620000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,65418000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62273000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32467000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,94740000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29322000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,268000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2310000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,106143000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,108185000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,78863000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-885000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,79748000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,79748000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,79748000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,371712000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,377435000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,379800000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:20:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,90971000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,90971000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8150000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8150000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,82821000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64178000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36301000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,100479000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17658000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,272000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2249000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1889000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3866000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13792000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-35000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13757000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13757000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13757000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,372246000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,372246000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,343900000.0
GW Pharmaceuticals PLC,GWPH,,0001351288,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 20:23:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
